Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular and Renal Effects of Valsartan in Hypertension
NCT00171353Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valsartan in hypertension (HTN) and albuminuria, sponsored by Novartis. Primary endpoints: Change from baseline in urine albumin excretion at 24 weeks and Change from baseline in an ultrasound measurement of blood flow at 24 weeks. Started Jul 2004; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)albuminuria
Beyond the preview
Go deeper on NCT00171353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171353.